ArticleFrontiers in immunology2023

Novel miRNA-based drug CD5-2 reduces liver tumor growth in diethylnitrosamine-treated mice by normalizing tumor vasculature and altering immune infiltrate.

Ken Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.